Thiago S Moreira Selected Research

carboxyphenylglycine

10/2011

Contribution of excitatory amino acid receptors of the retrotrapezoid nucleus to the sympathetic chemoreflex in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thiago S Moreira Research Topics

Disease

20	Hypercapnia 01/2022 - 02/2011
8	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
8	Hypoxia (Hypoxemia) 01/2022 - 12/2011
4	Hypotension (Low Blood Pressure) 01/2017 - 06/2007
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2020
1	Insulin Resistance 06/2022
1	Weight Gain 06/2022
1	Obesity 06/2022
1	Congenital central hypoventilation syndrome 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 02/2020
1	Temporal Lobe Epilepsy 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Necrosis 01/2018
1	Tachycardia (Tachyarrhythmias) 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Hypertension (High Blood Pressure) 10/2011
1	Body Weight (Weight, Body) 02/2009
1	Bradycardia 06/2007
1	Hypoventilation 10/2006

Drug/Important Bio-Agent (IBA)

7	Urethane (Ethyl Carbamate)IBA 01/2019 - 02/2011
6	MuscimolIBA 01/2018 - 02/2011
5	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 02/2011
4	Oxidopamine (6 Hydroxydopamine)IBA 01/2022 - 01/2017
4	SaporinsIBA 01/2020 - 01/2018
3	moxonidine (Moxon)IBA 01/2016 - 06/2007
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 03/2015
2	NBPhox proteinIBA 01/2021 - 10/2006
2	OrexinsIBA 01/2020 - 11/2018
2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2020 - 10/2011
2	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 01/2018
2	Kynurenic Acid (Kynurenate)IBA 11/2018 - 01/2016
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 11/2018 - 10/2018
2	Oxygen (Dioxygen)IBA 01/2018 - 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	LeptinIBA 06/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	anandamide (arachidonylethanolamide)IBA 01/2022
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Immunotoxins (Immunotoxin)IBA 01/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	Muscarinic M4 ReceptorIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	substance P-saporinIBA 11/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2018
1	Immunoglobulin G (IgG)IBA 11/2018
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	InterleukinsIBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2016
1	BicucullineIBA 01/2016
1	N-Methylaspartate (NMDA)IBA 01/2016
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2016
1	Excitatory Amino Acid AntagonistsIBA 01/2016
1	pyrrolidonyl-beta-naphthylamideIBA 07/2014
1	Stainless Steel (Steel, Stainless)IBA 12/2011
1	carboxyphenylglycineIBA 10/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2011
1	FG 9041 (DNQX)IBA 10/2011
1	Yohimbine (Yocon)IBA 06/2007

Therapy/Procedure

7	Injections 01/2020 - 02/2011
1	Denervation 02/2020
1	Cannula 12/2011